Table 2.

Therapy strategies in aneurysm SAH.

Agent	Administration	SAH model	Clinical effect	Treatment mechanism	Reference
Nicardipine/nimodipine	Oral/injection	Patient	Vasodilatation	Anti-inflammation	(287)
			Increase CBF		(288, 289)
Melatonin	Injection	Mouse	Attenuate brain edema		(84)
Dexmedetomidine	Injection	Mouse	Alleviate inflammation	Suppressed TLR4/NF-κB pathway	(290)
			Vasodilatation		(86, 291)
			Improve neurological function		(165)
Fingolimod	Oral	Mouse	Improve neurological outcome	Immunomodulatory	(292, 293)
Sunitinib	Oral	Patient	Aneurysms inhibition	PDGFRB mutation target	(26, 294)